CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

healthcarebusinessreview
US
EUROPE
APAC

About us

  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Magazine
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

Thank you for Subscribing to Healthcare Business Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How Pioneering Technologies Streamline and...

Andrew Parker, Vice President, Corporate Business...

Connected Care

Samuel Alfano DO, Medical Director, Clinical...

The [EHR] Doctor is in

Rebecca G. Mishuris, MD, MPH, MS, Chief Medical...

Hospitals Rely on New Technologies to...

Andrew Parker, Vice President-Human Resources &...

Medical Spine Care: Have We Finally Arrived?

Michael Geraci, Medical Director Comprehensive Spine...

The Modern Day Biomechanics

Julio Martinez, Medical Director, Baystate Health

Reducing Clinical Variation in Medicine...

Michael C. Sanders, M.D., Chief Medical Informatics...

Why Can't We Get Paid For Telehealth?

Samantha Lippolis, Director, Connected Care, UC Health

How Pioneering Technologies Streamline and...

Andrew Parker, Vice President, Corporate Business...

Connected Care

Samuel Alfano DO, Medical Director, Clinical...

The [EHR] Doctor is in

Rebecca G. Mishuris, MD, MPH, MS, Chief Medical...

Hospitals Rely on New Technologies to...

Andrew Parker, Vice President-Human Resources &...

Medical Spine Care: Have We Finally Arrived?

Michael Geraci, Medical Director Comprehensive Spine...

The Modern Day Biomechanics

Julio Martinez, Medical Director, Baystate Health

Reducing Clinical Variation in Medicine...

Michael C. Sanders, M.D., Chief Medical Informatics...

Why Can't We Get Paid For Telehealth?

Samantha Lippolis, Director, Connected Care, UC Health

3D Printed Talus Replacement

Jisun J. Lee, MS, DPM, Mica Murdoch, DPM, Ashley McClain, DPM, Broadlawns Medical Center
Tweet

Osteoarthritis (OA) is one of the most common causes of chronic disabling medical conditions in the United States, which affects about 27 million people and approximately 15 percent of the adult population. Among these, ankle OA occurs in 1 percent of the world population. Unlike the hip or the knee joint, the ankle joint is unique in the sense that it is more resistant to primary OA with efficient dispersing of greater body weights than the hip or the knee joint. It has been reported that the primary ankle OA comprises only 7 percent of ankle OA origin.


However, the talus is an irregular saddle–shaped bone that articulates with the tibia and fibula with minimal thickness of the cartilage of 1 to 1.7 mm. Tenuous vascular supply due to devoid muscular structure attachment of the talus further makes the talus predispose at risk of severe pathologic processes, especially with incongruity. Approximately 80 percent of the ankle OA cases are attributable to the posttraumatic origin, which will lead to ankle instability and joint incongruity. Moreover, posttraumatic OA develops nearly ten years earlier than primary OA and affects individuals at a younger age. The talus is also the 3rd most common anatomic location to develop avascular necrosis after a traumatic event. Other reported etiologies of advanced ankle OA are including but not limited to osteomyelitis, septic joint, rheumatoid, hemochromatosis, hemophilia, gout, neuropathic disease, bone tumor, and osteochondral lesions.


Treating end-stage ankle OA is still a challenge, yet tibiotalar arthrodesis is currently considered as an effective operative treatment. Total ankle replacement (TAR) is also considered as a safe and effective alternative. However, previous reports have demonstrated that the reoperation rate is approximately 20 percent and up to 50 percent tibiotalar arthrodesis and TAR, respectively. In case of poor bone quality with talar osteonecrosis, loss of talus due to trauma or infection, or failed TAR due to hardware loosening or significant substance, 3D printed talus replacement is a valid and promising operative management option.


A custom-designed talus replacement was first published by Harnroongroj T and Vanadurongwan V with first-generation talar body prosthesis in 1997. First-generation talar prosthesis preserved the head and neck of the talus to allow the insertion of the prosthetic peg into the bone. Then, in 1999, Tanaka Y et al. designed second-generation alumina-ceramic talar body prosthesis without a peg for the neck of the talus. In 2005, Taniguchi et al. reported excellent pain and functional outcomes in 55 ankles with a total talar replacement (TTR).


Treating end-stage ankle OA is still a challenge, yet tibiotalar arthrodesis is currently considered as an effective operative treatment


The contralateral talus is utilized for radiographic data and computed tomography (CT) to obtain a 3dimensional model to replicate its biomechanical and anatomical properties. Patient-specific and anatomic based design talar prosthesis will be constructed with 3D printed using polymeric biocompatible powders. Production of TTR generally requires 4 to 6 weeks for completion and stainless still, titanium, alumina ceramic, and cobalt chrome are the most commonly used materials.


The most commonly used surgical approach is the anterior ankle approach, where a 10 to 14 cm anterior longitudinal midline incision is made to the talonavicular joint level. Care should be taken to identify and protect all vital neurovascular structures. Upon performing an anterior capsulotomy, the ankle joint is exposed after the elevation of the periosteum. Then the talar body is carefully dissected out for complete extrusion. Any remaining osteophyte should also be removed. Then appropriate soft tissue manipulation was performed to maintain a functional ankle joint space. The new custom-built implant was then fitted into the patient’s ankle, and the most appropriate fit of the polyethylene component is inserted after trial polyethylenes were tried. Insertion of the tibial portion of the arthroplasty system is also carried out with the system based on the surgeon’s choice. A gastrocnemius recession or Achilles tendon lengthening is required when it is clinically indicated. A below-knee cast will be applied for two weeks then the patient will begin weight-bearing in a CAM boot. Then supportive shoes and a lace-up ankle brace will be used at 6 to 8 weeks. Outcomes will be measured by inspecting maintained postoperative ankle range of motion as well as clinical and functional surveys such as the AOFAS score and SF–36.


Highlighted benefits of the TTR are a good restoration of the physiological motion without limb length shortening as demonstrated in multiple studies. TTR also produces stability with preventing degenerative changes to adjacent joints and dispersing pressures appropriately. Thus, TTR is an excellent surgical treatment option for patients with advanced OA from trauma, talar osteonecrosis, infectious origin, talus bone tumor, and failed TAR.


Weekly Brief

loading
Top Featured Vendor Jan - Feb - 2021
> <
  • Medical Equipment Maintenance 2022

    Top Vendors

    Current Issue
  • Long Term Care 2022

    Top Vendors

    Current Issue
  • Healthcare Facilities Management 2022

    Top Vendors

    Current Issue
  • Healthcare Bpo 2022

    Top Vendors

    Current Issue

Read Also

Home care: The Next Frontier in Healthcare Innovation

Steve Peterson, Regional Therapy Director, Advanced Health Care Corporation
Home care: The Next Frontier in Healthcare Innovation

Restart, Recover, and Reimagine

Alexander Koster, Director, VBSO Analytics & Technology, Nemours
Restart, Recover, and Reimagine

Cellular Therapy: The next crossroad in cancer care

Mike Koroscik, Vice President, Allina Health Cancer Institute
Cellular Therapy: The next crossroad in cancer care

NYU Langone Health: Continuing Excellence in Healthcare at Home

Dr. Paul Testa, Chief Medical Information Officer, NYU Langone Health
NYU Langone Health: Continuing Excellence in Healthcare at Home
The Role of Inventory Management in Healthcare

The Role of Inventory Management in Healthcare

Patrick Donovan, Director of Supply Chain Decision Support, Providence Health & Services
Electronic Procurement for Implants: Let's Do This!

Electronic Procurement for Implants: Let's Do This!

Jack Koczela, Director - Supply Chain Services, Froedtert Health

Leveraging Technology to Improve Healthcare

Derek Kissos, Chief Growth Officer, HHS
Leveraging Technology to Improve Healthcare

How Hospice Careis Evolving: Managing End-of-Life Pain with Care, Collaboration and Compassion

Dr. Joseph Shega, Executive Vice President and Chief Medical Officer, VITAS Healthcare
How Hospice Careis Evolving: Managing End-of-Life Pain with Care, Collaboration and Compassion
Loading...

Copyright © 2022 Healthcare Business Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessreview.com/cxoinsight/3d-printed-talus-replacement-nwid-34.html